19 December 2011 - US diversified healthcare company Baxter International Inc (NYSE:BAX) said on Friday the US Food and Drug Administration (FDA) had cleared ADVATE [Antihemophilic Factor (Recombinant) Plasma/Albumin Free Method] for general prophylactic use to prevent or lower the number of bleedin...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up